Drug Profile
Influenza A virus H5N1 vaccine - Solvay
Alternative Names: Pandemic H5N1 egg-based vaccine - SolvayLatest Information Update: 03 Jun 2009
Price :
$50
*
At a glance
- Originator Solvay Pharmaceuticals
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza A virus H5N1 subtype